Vitamin A Supplementation and Serum Th1- and Th2-Associated Cytokine Response in Women
dc.contributor.author | Farhangi, MA | |
dc.contributor.author | Keshavarz, SA | |
dc.contributor.author | Eshraghian, M | |
dc.contributor.author | Ostadrahimi, A | |
dc.contributor.author | Saboor-Yaraghi, A-A | |
dc.date.accessioned | 2018-08-26T09:45:06Z | |
dc.date.available | 2018-08-26T09:45:06Z | |
dc.date.issued | 2013 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/58712 | |
dc.description.abstract | Aims and Background: T helper (Th)1/Th2 immune response has been linked to obesity-related immune disorders. It has been proven that retinoid active derivates improve immunity via regulating Th1/Th2 balance. However, there is not a well-identified report of direct effect of vitamin A on Th1/Th2 balance in obesity. The present study aimed to investigate the possible role of vitamin A on serum Th1/Th2 response in obese women. Materials and Methods: A randomized double-blind placebo-controlled trial was conducted on 84 obese (n = 56; body mass index [BMI] 30-39.9 kg/m2) and nonobese (n = 28; BMI 18.5-24.9 kg/m2) women. Obese women were randomly allocated to receive either vitamin A (retinyl palmitate 25,000 IU/d) or placebo. Nonobese women also received 25,000 IU/d retinyl palmitate. Anthropometric variables were assessed and serum interleukin (IL)-1?, tumor necrosis factor (TNF)-?, IL-4, and IL-13 were analyzed before and 4 months after intervention. Results: Vitamin A treatment significantly reduced serum concentrations of IL-1? in obese vitamin A-treated subjects (from 3.58 ± 0.36 to 2.45 ± 0.23 pg/ml, p < 0.006). Serum concentrations of IL-4 and IL-13 were also reduced in obese and nonobese vitamin A-treated subjects (p < 0.05). A significant reduction in IL-1?/IL-4 ratio in the obese vitamin A-treated group was also observed (p = 0.03). Conclusions: Decline in serum concentrations of IL-1? and IL-1?/IL-4 ratio in obese women suggests that vitamin A is capable of regulating the immune system and possibly reducing the risk of autoimmune disease in this group. Further studies are needed to explore the possible underlying mechanisms. © 2013 Copyright Taylor and Francis Group, LLC. | |
dc.language.iso | English | |
dc.relation.ispartof | Journal of the American College of Nutrition | |
dc.subject | interleukin 13 | |
dc.subject | interleukin 1beta | |
dc.subject | interleukin 4 | |
dc.subject | placebo | |
dc.subject | retinol palmitate | |
dc.subject | tumor necrosis factor alpha | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | controlled study | |
dc.subject | cytokine production | |
dc.subject | cytokine response | |
dc.subject | double blind procedure | |
dc.subject | female | |
dc.subject | human | |
dc.subject | immune system | |
dc.subject | major clinical study | |
dc.subject | obesity | |
dc.subject | prevalence | |
dc.subject | randomized controlled trial (topic) | |
dc.subject | risk factor | |
dc.subject | Th1 cell | |
dc.subject | Th2 cell | |
dc.subject | vitamin supplementation | |
dc.subject | Adult | |
dc.subject | Body Mass Index | |
dc.subject | Cytokines | |
dc.subject | Dietary Supplements | |
dc.subject | Double-Blind Method | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Interleukin-13 | |
dc.subject | Interleukin-1beta | |
dc.subject | Interleukin-4 | |
dc.subject | Obesity | |
dc.subject | Th1-Th2 Balance | |
dc.subject | Tumor Necrosis Factor-alpha | |
dc.subject | Vitamin A | |
dc.title | Vitamin A Supplementation and Serum Th1- and Th2-Associated Cytokine Response in Women | |
dc.type | Article | |
dc.citation.volume | 32 | |
dc.citation.issue | 4 | |
dc.citation.spage | 280 | |
dc.citation.epage | 285 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.1080/07315724.2013.816616 |